Koers Cerenis Therapeutics Holding Euronext Paris
Aandelen
FR0012616852
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 4,6 mln. 4,95 mln. | Omzet 2024 * | 4,6 mln. 4,95 mln. | Marktkapitalisatie | 33,49 mln. 36,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -3 mln. -3,23 mln. | Nettowinst (verlies) 2024 * | -6 mln. -6,46 mln. | EV/omzet 2023 | 9,02 x |
Nettoliquiditeiten 2023 * | 100K 108K | Nettoliquiditeiten 2024 * | 3,4 mln. 3,66 mln. | EV/omzet 2024 * | 6,54 x |
K/w-verhouding 2023 * |
-7,43
x | K/w-verhouding 2024 * |
-6,93
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 68,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 01-01-07 |
Director of Finance/CFO | - | 01-05-08 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 09-02-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 06-02-15 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 01-01-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |